Patient Guide: Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 26 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06182774
Status: 🟢 Enrolling Now
Condition: Multiple Myeloma
Phase: PHASE3

Where You Can Participate

This study is available at 26 locations across the country.

Top locations include:
  • • Kelowna, British Columbia
  • • Vancouver, British Columbia
  • • Winnipeg, Manitoba
  • • And 23 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma - Join Clinical Trial NCTNCT06182774

How to Join This Clinical Trial - NCTNCT06182774

Learn how to participate in this PHASE3 trial studying an investigational therapy for Multiple Myeloma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06182774 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 26 locations. Find a study site near you:

Clinical Research Site

Kelowna, British Columbia V1Y 5L3 - Canada

Status: RECRUITING

Clinical Research Site

Vancouver, British Columbia V5Z 4E6 - Canada

Status: RECRUITING

Clinical Research Site

Winnipeg, Manitoba R3E 0V9 - Canada

Status: RECRUITING

Clinical Research Site

Moncton, New Brunswick E1C 6Z8 - Canada

Status: RECRUITING

Clinical Research Site

Saint John, New Brunswick E2L 4L2 - Canada

Status: RECRUITING

Clinical Research Site

St. John's, Newfoundland and Labrador A1B 3V6 - Canada

Status: RECRUITING

Clinical Research Site

Barrie, Ontario L4M 6M2 - Canada

Status: RECRUITING

Clinical Research Site

Brampton, Ontario L6R 3J7 - Canada

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario L8V 5C2 - Canada

Status: RECRUITING

Clinical Research Site

Kingston, Ontario K7L 2V7 - Canada

Status: RECRUITING

And 16 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships